These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 20488163)

  • 1. Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels.
    Villalonga N; David M; Bielańska J; González T; Parra D; Soler C; Comes N; Valenzuela C; Felipe A
    Biochem Pharmacol; 2010 Sep; 80(6):858-66. PubMed ID: 20488163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages.
    Villalonga N; Escalada A; Vicente R; Sánchez-Tilló E; Celada A; Solsona C; Felipe A
    Biochem Biophys Res Commun; 2007 Jan; 352(4):913-8. PubMed ID: 17157812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kv1.3 potassium channels as a therapeutic target in multiple sclerosis.
    Rangaraju S; Chi V; Pennington MW; Chandy KG
    Expert Opin Ther Targets; 2009 Aug; 13(8):909-24. PubMed ID: 19538097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18β-Glycyrrhetinic acid potently inhibits Kv1.3 potassium channels and T cell activation in human Jurkat T cells.
    Fu XX; Du LL; Zhao N; Dong Q; Liao YH; Du YM
    J Ethnopharmacol; 2013 Jul; 148(2):647-54. PubMed ID: 23707333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCNE4 suppresses Kv1.3 currents by modulating trafficking, surface expression and channel gating.
    Solé L; Roura-Ferrer M; Pérez-Verdaguer M; Oliveras A; Calvo M; Fernández-Fernández JM; Felipe A
    J Cell Sci; 2009 Oct; 122(Pt 20):3738-48. PubMed ID: 19773357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diclofenac inhibits Kv1.3 and Kir2.1 expressions in human macrophages and affects the membrane potential and foam cell formation.
    Lei X; Zhang W; Lin X; Wang D; Yuan Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Aug; 32(8):1067-73. PubMed ID: 22931594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting effector memory T-cells with Kv1.3 blockers.
    Wulff H; Pennington M
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):438-45. PubMed ID: 17659485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TNF-alpha inhibits the CD3-mediated upregulation of voltage-gated K+ channel (Kv1.3) in human T cells.
    Pang B; Zheng H; Shin DH; Jung KC; Ko JH; Lee KY; Kang TM; Kim SJ
    Biochem Biophys Res Commun; 2010 Jan; 391(1):909-14. PubMed ID: 19951698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms for Kv1.3 potassium channel current inhibition by CD3/CD28 stimulation in Jurkat T cells.
    Matsushita Y; Ohya S; Itoda H; Kimura T; Suzuki Y; Yamamura H; Imaizumi Y
    Biochem Biophys Res Commun; 2008 Sep; 374(1):152-7. PubMed ID: 18611390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators.
    Vennekamp J; Wulff H; Beeton C; Calabresi PA; Grissmer S; Hänsel W; Chandy KG
    Mol Pharmacol; 2004 Jun; 65(6):1364-74. PubMed ID: 15155830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
    Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
    J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effects of nonsteroidal anti-inflammatory drugs diclofenac sodium, salicylate and indomethacin on delayed rectifier K+-channel currents in murine thymocytes.
    Kazama I; Maruyama Y; Murata Y
    Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):874-8. PubMed ID: 22409730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune Diseases.
    Zhao Y; Huang J; Yuan X; Peng B; Liu W; Han S; He X
    Toxins (Basel); 2015 May; 7(5):1749-64. PubMed ID: 25996605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lovastatin blocks Kv1.3 channel in human T cells: a new mechanism to explain its immunomodulatory properties.
    Zhao N; Dong Q; Qian C; Li S; Wu QF; Ding D; Li J; Wang BB; Guo KF; Xie JJ; Cheng X; Liao YH; Du YM
    Sci Rep; 2015 Nov; 5():17381. PubMed ID: 26616555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diclofenac, a nonsteroidal anti-inflammatory drug, activates the transient outward K+ current in rat cerebellar granule cells.
    Liu LY; Fei XW; Li ZM; Zhang ZH; Mei YA
    Neuropharmacology; 2005 May; 48(6):918-26. PubMed ID: 15829261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The voltage-gated potassium channel Kv1.3 is a promising multitherapeutic target against human pathologies.
    Pérez-Verdaguer M; Capera J; Serrano-Novillo C; Estadella I; Sastre D; Felipe A
    Expert Opin Ther Targets; 2016; 20(5):577-91. PubMed ID: 26634786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting rheumatoid arthritis: Kv1.3 as a therapeutic target.
    Serrano-Albarrás A; Cirera-Rocosa S; Sastre D; Estadella I; Felipe A
    Biochem Pharmacol; 2019 Jul; 165():214-220. PubMed ID: 30878554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases.
    Schmitz A; Sankaranarayanan A; Azam P; Schmidt-Lassen K; Homerick D; Hänsel W; Wulff H
    Mol Pharmacol; 2005 Nov; 68(5):1254-70. PubMed ID: 16099841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kv1.3 channel blockade enhances the phagocytic function of RAW264.7 macrophages.
    Zhu H; Yan L; Gu J; Hao W; Cao J
    Sci China Life Sci; 2015 Sep; 58(9):867-75. PubMed ID: 26354506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ion channels, Ca2+ signaling, and reporter gene expression in antigen-specific mouse T cells.
    Kerschbaum HH; Negulescu PA; Cahalan MD
    J Immunol; 1997 Aug; 159(4):1628-38. PubMed ID: 9257822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.